Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers
- 1 April 2005
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 100 (2) , 207-212
- https://doi.org/10.1016/j.ijcard.2004.05.046
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Changes of Plasma Concentrations of Soluble Vascular Cell Adhesion Molecule-1 and Vascular Endothelial Growth Factor after Increased Perfusion of Lower Extremities in HumansEndothelium, 2003
- Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetesClinical Science, 2002
- Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassaysClinical Science, 2001
- Interindividual Heterogeneity in the Hypoxic Regulation of VEGFCirculation, 1999
- Vascular Endothelial Growth Factor (VEGF) Expression in Human Coronary Atherosclerotic LesionsCirculation, 1998
- VEGF-A Induces Expression of eNOS and iNOS in Endothelial Cells via VEGF Receptor-2 (KDR)Biochemical and Biophysical Research Communications, 1998
- Differential Binding Characteristics and Cellular Inhibition by Soluble VEGF Receptors 1 and 2Experimental Cell Research, 1998
- Mechanisms of angiogenesisNature, 1997
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993